Innospec (NASDAQ:IOSP) Director David Landless Sells 594 Shares of Stock

Innospec Inc. (NASDAQ:IOSP) Director David Landless sold 594 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the sale, the director directly owned 7,632 shares in the company, valued at $584,305.92. This trade represents a 7.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Innospec Price Performance

NASDAQ:IOSP opened at $76.37 on Wednesday. Innospec Inc. has a one year low of $70.10 and a one year high of $102.25. The company has a fifty day moving average price of $81.07 and a 200 day moving average price of $79.08. The stock has a market cap of $1.89 billion, a P/E ratio of 16.32, a PEG ratio of 2.03 and a beta of 0.90.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, February 17th. The specialty chemicals company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.24. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The company had revenue of $455.60 million for the quarter, compared to the consensus estimate of $460.87 million. During the same quarter in the previous year, the firm posted $1.41 EPS. The business’s revenue was down 2.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Innospec Inc. will post 6.18 EPS for the current year.

Hedge Funds Weigh In On Innospec

A number of institutional investors have recently modified their holdings of IOSP. Dimensional Fund Advisors LP lifted its holdings in Innospec by 0.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,175,122 shares of the specialty chemicals company’s stock worth $89,946,000 after buying an additional 8,147 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Innospec by 13.7% during the 4th quarter. Victory Capital Management Inc. now owns 950,074 shares of the specialty chemicals company’s stock valued at $72,719,000 after acquiring an additional 114,179 shares during the last quarter. State Street Corp grew its stake in shares of Innospec by 2.1% during the fourth quarter. State Street Corp now owns 949,038 shares of the specialty chemicals company’s stock worth $72,639,000 after purchasing an additional 19,915 shares during the period. Geode Capital Management LLC increased its holdings in Innospec by 2.1% in the second quarter. Geode Capital Management LLC now owns 719,598 shares of the specialty chemicals company’s stock valued at $60,517,000 after purchasing an additional 14,463 shares during the last quarter. Finally, Millennium Management LLC lifted its stake in Innospec by 10.8% in the fourth quarter. Millennium Management LLC now owns 533,312 shares of the specialty chemicals company’s stock valued at $40,820,000 after buying an additional 51,824 shares during the period. 96.64% of the stock is owned by institutional investors.

Innospec News Summary

Here are the key news stories impacting Innospec this week:

• Neutral Sentiment: Short-interest update published; may affect near-term trading dynamics depending on whether shorts rose or fell. Short Interest Update
• Negative Sentiment: SVP David B. Jones sold 1,028 shares at an average $75.64 (≈$77.8k); his stake fell ~6.5%. Insider sale disclosed in an SEC filing. David B. Jones Sale
• Negative Sentiment: Director David Landless sold 594 shares at $76.56 (≈$45.5k); his holding dropped ~7.2%. Sale disclosed to the SEC. David Landless Sale
• Negative Sentiment: Director Claudia Poccia sold 119 shares at $76.56 (≈$9.1k); her stake fell ~1.8%. Sale disclosed in an SEC filing. Claudia Poccia SEC Filing
• Negative Sentiment: Director Larry Padfield sold 594 shares at $76.56 (≈$45.5k); his holding fell ~5.9%. Sale disclosed to the SEC. Larry Padfield Sale
• Negative Sentiment: Director Milton C. Blackmore sold 594 shares at $76.56 (≈$45.5k); his position declined ~5.3%. Sale disclosed to the SEC. Milton C. Blackmore Sale

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on IOSP shares. Zacks Research cut shares of Innospec from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 19th. Wall Street Zen upgraded shares of Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. Finally, Weiss Ratings raised Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, February 19th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.